Climb Bio to Present at Upcoming Investor Conferences
Climb Bio (Nasdaq: CLYM) announced that its executive team will participate in two upcoming investor conferences in March 2025. The company will attend the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 9:50 a.m. ET, featuring a formal presentation and one-on-one investor meetings. A webcast link is provided for virtual attendance.
Additionally, Climb Bio will participate in Leerink's Global Healthcare Conference 2025 on March 10, 2025, at 10:00 a.m. ET. This event will include a fireside chat format and one-on-one investor meetings, with a webcast link also available. The announcement was made from the company's Wellesley, Massachusetts headquarters on February 25, 2025.
Climb Bio (Nasdaq: CLYM) ha annunciato che il suo team esecutivo parteciperà a due prossimi conferenze per investitori a marzo 2025. L'azienda parteciperà al 45° Congresso Annuale sulla Salute di TD Cowen il 4 marzo 2025, alle 9:50 ET, con una presentazione formale e incontri individuali con gli investitori. È fornito un link per la partecipazione virtuale.
Inoltre, Climb Bio parteciperà al Global Healthcare Conference 2025 di Leerink il 10 marzo 2025, alle 10:00 ET. Questo evento includerà un formato di conversazione informale e incontri individuali con gli investitori, con un link per la trasmissione disponibile. L'annuncio è stato fatto dalla sede dell'azienda a Wellesley, Massachusetts, il 25 febbraio 2025.
Climb Bio (Nasdaq: CLYM) anunció que su equipo ejecutivo participará en dos próximas conferencias para inversores en marzo de 2025. La compañía asistirá a la 45ª Conferencia Anual de Salud de TD Cowen el 4 de marzo de 2025, a las 9:50 a.m. ET, con una presentación formal y reuniones individuales con inversores. Se proporciona un enlace para la asistencia virtual.
Además, Climb Bio participará en la Conferencia Global de Salud 2025 de Leerink el 10 de marzo de 2025, a las 10:00 a.m. ET. Este evento incluirá un formato de charla informal y reuniones individuales con inversores, con un enlace para la transmisión también disponible. El anuncio se realizó desde la sede de la empresa en Wellesley, Massachusetts, el 25 de febrero de 2025.
Climb Bio (Nasdaq: CLYM)는 2025년 3월에 있을 두 개의 투자자 회의에 경영진이 참석할 것이라고 발표했습니다. 회사는 2025년 3월 4일 오전 9시 50분 ET에 TD Cowen 제45회 연례 건강 관리 회의에 참석하며, 공식 발표와 1:1 투자자 미팅이 진행됩니다. 가상 참석을 위한 웹캐스트 링크가 제공됩니다.
또한, Climb Bio는 2025년 3월 10일 오전 10시 ET에 Leerink의 글로벌 헬스케어 회의 2025에 참석할 예정입니다. 이 행사에서는 대화 형식의 세션과 1:1 투자자 미팅이 포함되며, 웹캐스트 링크도 제공됩니다. 이 발표는 2025년 2월 25일 매사추세츠주 웰즐리의 본사에서 이루어졌습니다.
Climb Bio (Nasdaq: CLYM) a annoncé que son équipe de direction participera à deux prochaines conférences pour investisseurs en mars 2025. La société assistera à la 45e Conférence Annuelle sur la Santé de TD Cowen le 4 mars 2025 à 9h50 ET, avec une présentation formelle et des réunions individuelles avec les investisseurs. Un lien pour la participation virtuelle est fourni.
De plus, Climb Bio participera à la Conférence Mondiale sur la Santé 2025 de Leerink le 10 mars 2025 à 10h00 ET. Cet événement comprendra un format de discussion informelle et des réunions individuelles avec les investisseurs, avec également un lien pour la diffusion disponible. L'annonce a été faite depuis le siège de l'entreprise à Wellesley, Massachusetts, le 25 février 2025.
Climb Bio (Nasdaq: CLYM) gab bekannt, dass sein Führungsteam an zwei bevorstehenden Investorenkonferenzen im März 2025 teilnehmen wird. Das Unternehmen wird am 4. März 2025 um 9:50 Uhr ET an der 45. jährlichen Gesundheitskonferenz von TD Cowen teilnehmen, die eine formelle Präsentation und Einzelgespräche mit Investoren umfasst. Ein Link zur virtuellen Teilnahme wird bereitgestellt.
Zusätzlich wird Climb Bio am 10. März 2025 um 10:00 Uhr ET an der Global Healthcare Conference 2025 von Leerink teilnehmen. Diese Veranstaltung wird ein informelles Gesprächsformat und Einzelgespräche mit Investoren umfassen, wobei ebenfalls ein Link zur Übertragung zur Verfügung steht. Die Ankündigung wurde am 25. Februar 2025 von der Unternehmenszentrale in Wellesley, Massachusetts, gemacht.
- None.
- None.
WELLESLEY, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate in the upcoming investor conferences detailed below.
TD Cowen 45th Annual Health Care Conference
Format: Formal presentation and one-on-one investor meetings
Date: March 4, 2025
Time: 9:50 a.m. ET
Webcast: Click here
Leerink’s Global Healthcare Conference 2025
Format: Fireside chat and one-on-one investor meetings
Date: March 10, 2025
Time: 10:00 a.m. ET
Webcast: Click here
About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.
Investors
Chris Brinzey
ICR Healthcare
chris.brinzey@icrhealthcare.com
339-970-2843
Media
Jon Yu
ICR Healthcare
jon.yu@icrhealthcare.com
475-395-5375
FAQ
When will Climb Bio (CLYM) present at the TD Cowen Health Care Conference in 2025?
What format will Climb Bio's presentation take at Leerink's Global Healthcare Conference 2025?
Are webcasts available for Climb Bio's (CLYM) March 2025 investor conference presentations?
How many investor conferences will Climb Bio (CLYM) attend in March 2025?
What types of meetings will Climb Bio executives conduct during the March 2025 conferences?
